Alprazolam

Product NDC: 49999-252
11-digit product format: 499990252
Labeler code: 49999
Product ID: 49999-252_d9bb7212-1075-4735-ae43-5c9107528463
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Alprazolam
Dosage form: TABLET
Route: ORAL
Labeler: Quality Care Products LLC
Application: NDA018276
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2011-11-15
Marketing end: 0000-00-00
Substance: ALPRAZOLAM
Active strength: 1 mg/1
Pharmacologic classes: Benzodiazepine [EPC], Benzodiazepines [CS]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	49999-252		D	Discontinued by firm	2026-10-16
excluded package	package	49999-252	49999-252-00	D	Discontinued by firm	2026-10-16
excluded package	package	49999-252	49999-252-10	D	Discontinued by firm	2026-10-16
excluded package	package	49999-252	49999-252-30	D	Discontinued by firm	2026-10-16
excluded package	package	49999-252	49999-252-60	D	Discontinued by firm	2026-10-16
excluded package	package	49999-252	49999-252-90	D	Discontinued by firm	2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 2 of 2 · 78 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	49999-252-60	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	49999-252-90	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	49999-252-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	49999-252-00	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	49999-252-10	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	49999-252-60	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	49999-252-90	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	49999-252-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	49999-252-00	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	49999-252-10	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	49999-252-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	49999-252-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	49999-252-30	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N018276-001	XANAX	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982
N018276-002	XANAX	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982
N018276-003	XANAX	ALPRAZOLAM	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982
N018276-004	XANAX	ALPRAZOLAM	2MG	TABLET / ORAL	AB	RLD	1985-11-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
N018276-001	AB
N018276-002	AB
N018276-003	AB
N018276-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018276-001	XANAX	0.25MG	TABLET / ORAL	AB	RLD, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018276-002	XANAX	0.5MG	TABLET / ORAL	AB	RLD, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018276-003	XANAX	1MG	TABLET / ORAL	AB	RLD, RS, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018276-004	XANAX	2MG	TABLET / ORAL	AB	RLD	1985-11-27	`2680178bc6a6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	N018276-001	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018276-002	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018276-003	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N018276-004	AB	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N018276-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018276-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018276-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N018276-004	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N018276-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018276-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018276-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N018276-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N018276-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018276-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018276-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N018276-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018276-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018276-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018276-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N018276-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N018276-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018276-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018276-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N018276-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018276-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018276-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018276-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N018276-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018276-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018276-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018276-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N018276-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018276-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018276-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018276-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N018276-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018276-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018276-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018276-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N018276-004	AB	1	`2680178bc6a6…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
49999-252-00	2024-11-20	Alprazolam Tablets, USP CIV
49999-252-10	2024-11-20	Alprazolam Tablets, USP CIV
49999-252-30	2024-11-20	Alprazolam Tablets, USP CIV
49999-252-60	2024-11-20	Alprazolam Tablets, USP CIV
49999-252-90	2024-11-20	Alprazolam Tablets, USP CIV
49999-252-00	2024-01-30	Alprazolam Tablets, USP CIV
49999-252-10	2024-01-30	Alprazolam Tablets, USP CIV
49999-252-30	2024-01-30	Alprazolam Tablets, USP CIV
49999-252-60	2024-01-30	Alprazolam Tablets, USP CIV
49999-252-90	2024-01-30	Alprazolam Tablets, USP CIV

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
49999-252-00	EA - Each	49999-252	67f7624f-a17b-4aa6-87fc-e1e8cc2b5106	1	2012-07-24
49999-252-10	EA - Each	49999-252	51153605-fff6-4720-955b-2c76dd785a24	1	2012-07-24
49999-252-30	EA - Each	49999-252	dd477a3a-78a1-434e-bb44-b3ad52f17521	1	2012-07-24
49999-252-60	EA - Each	49999-252	49666bd8-8f09-4748-b879-4d9f7cc8f1be	1	2012-07-24
49999-252-90	EA - Each	49999-252	99d0dbe1-ac21-4f18-96f8-0e26e33381aa	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
alprazolam	ACTIVE INGREDIENT	YU55MQ3IZY	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751
alprazolam	ACTIVE MOIETY	YU55MQ3IZY	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751
docusate sodium	INACTIVE INGREDIENT	F05Q2T2JA0	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751
FD&C Blue No. 2	INACTIVE INGREDIENT	L06K8R7DQK	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751
lactose	INACTIVE INGREDIENT	J2B2A4N98G	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751
Powdered Cellulose	INACTIVE INGREDIENT	SMD1X3XO9M	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751
sodium benzoate	INACTIVE INGREDIENT	OJ245FE5EU	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751
starch, corn	INACTIVE INGREDIENT	O8232NY3SJ	ALPRAZOLAM TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]	32751

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Alprazolam	ALPRAZOLAM	Mylan Pharmaceuticals Inc.	13930c94-d83a-414f-be35-b1fef35f738d	2025-01-15	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018276 application number: NDA018276
Alprazolam	ALPRAZOLAM	Asclemed USA, Inc.	e3245259-024f-4bd9-9ec6-94aa11febfd7	2024-01-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018276 application number: NDA018276
Alprazolam	ALPRAZOLAM	Proficient Rx LP	60c90b4b-174f-4fd2-b65f-fc166c16bdc1	2023-10-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018276 application number: NDA018276
Alprazolam	ALPRAZOLAM	Proficient Rx LP	10de2b3b-3b3f-4a5a-a9e7-a8401f53b8cc	2023-08-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018276 application number: NDA018276
Xanax	ALPRAZOLAM	PHARMACIA & UPJOHN COMPANY LLC	388e249d-b9b6-44c3-9f8f-880eced0239f	2023-01-18	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018276 application number: NDA018276
Alprazolam	ALPRAZOLAM	Proficient Rx LP	4579facb-b225-4108-a5ef-dada926ef7cf	2022-04-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018276 application number: NDA018276
Alprazolam	ALPRAZOLAM	Proficient Rx LP	f6990b57-7011-4cdf-8abc-1794e2e0c7f1	2019-11-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018276 application number: NDA018276
Alprazolam	ALPRAZOLAM	Aphena Pharma Solutions - Tennessee, LLC	964d7f43-34a6-45af-a95f-3b9ade17c6a5	2018-02-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 018276 application number: NDA018276

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
YU55MQ3IZY	ALPRAZOLAM	28981-97-7	ALPRAZOLAM

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
49999-252-30	49999025230	30 TABLET in 1 BOTTLE (49999-252-30)	30 tablet	2021-12-03	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Alprazolam Tablets, USP CIV	Quality Care Products LLC	2022-08-18	HUMAN PRESCRIPTION DRUG LABEL	32758